Back to Search Start Over

Fructose impairs fat oxidation: Implications for the mechanism of western diet-induced NAFLD.

Authors :
Inci MK
Park SH
Helsley RN
Attia SL
Softic S
Source :
The Journal of nutritional biochemistry [J Nutr Biochem] 2023 Apr; Vol. 114, pp. 109224. Date of Electronic Publication: 2022 Nov 18.
Publication Year :
2023

Abstract

Increased fructose intake from sugar-sweetened beverages and highly processed sweets is a well-recognized risk factor for the development of obesity and its complications. Fructose strongly supports lipogenesis on a normal chow diet by providing both, a substrate for lipid synthesis and activation of lipogenic transcription factors. However, the negative health consequences of dietary sugar are best observed with the concomitant intake of a HFD. Indeed, the most commonly used obesogenic research diets, such as "Western diet", contain both fructose and a high amount of fat. In spite of its common use, how the combined intake of fructose and fat synergistically supports development of metabolic complications is not fully elucidated. Here we present the preponderance of evidence that fructose consumption decreases oxidation of dietary fat in human and animal studies. We provide a detailed review of the mitochondrial β-oxidation pathway. Fructose affects hepatic activation of fatty acyl-CoAs, decreases acylcarnitine production and impairs the carnitine shuttle. Mechanistically, fructose suppresses transcriptional activity of PPARα and its target CPT1α, the rate limiting enzyme of acylcarnitine production. These effects of fructose may be, in part, mediated by protein acetylation. Acetylation of PGC1α, a co-activator of PPARα and acetylation of CPT1α, in part, account for fructose-impaired acylcarnitine production. Interestingly, metabolic effects of fructose in the liver can be largely overcome by carnitine supplementation. In summary, fructose decreases oxidation of dietary fat in the liver, in part, by impairing acylcarnitine production, offering one explanation for the synergistic effects of these nutrients on the development of metabolic complications, such as NAFLD.<br />Competing Interests: Declaration of Competing Interests The authors declare that there are no conflicts of interest.<br /> (Copyright © 2022 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1873-4847
Volume :
114
Database :
MEDLINE
Journal :
The Journal of nutritional biochemistry
Publication Type :
Academic Journal
Accession number :
36403701
Full Text :
https://doi.org/10.1016/j.jnutbio.2022.109224